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c o n c i s e c o m m u n i c a t i o n
table 1. Organisms Isolated From Patients With Deep and Su-
perficial Surgical Site Infections (SSIs)
Organism







CoNS 18 (45) 8 (33) 10 (63)
Staphylococcus aureus 11 (28) 5 (21) 6 (38)
MRSA 5 (13) 3 (13) 2 (13)
Pseudomonas aeruginosa 2 (5) 2 (8) 0
Klebsiella pneumoniae 2 (5) 2 (8) 0
Candida albicans 1 (3) 1 (4) 0
Enterococcus spp 2 (5) 2 (8) 0
Acinetobacter spp 1 (3) 1 (4) 0
Haemophilus influenzae 1 (3) 1 (4) 0
Serratia marcescens 1 (3) 0 1 (6)
Other 2 (5) 1 (4) 1 (6)
No growth 1 (3) 1 (4) 0
note. Six infections were polymicrobial. CoNS, coagulase-negativestaph-
ylococci; MRSA, methicillin-resistant S. aureus.
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A retrospective case-control study was performed to determine the
risks and outcomes associated with pediatric cardiothoracic surgical
site infection. Undergoing more than 1 cardiothoracic operative pro-
cedure, having preoperative infection, and undergoing surgery on
a Monday were significant risk factors. Cardiothoracic surgical site
infection increased hospital and pediatric intensive care unit length
of stay. Deep surgical site infection significantly increased mortality.
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Published data regarding the incidence of cardiothoracic sur-
gical site infection (SSI) in pediatric patients are limited. Pub-
lished rates of pediatric cardiothoracic SSI range from 2.3%
to 5.0%.1-3 Few studies control for severity of illness or use
multivariate analysis. In controlled studies, the independent
risk factors identified for pediatric cardiothoracic SSI include
duration of surgery, young age, presence of upper respiratory
tract infection, and hypothermia.2,4,5
Controlling for underlying severity of illness is challenging
because adequate preoperative risk stratification for pediatric
patients is lacking. Several studies control for severity of ill-
ness using the American Society of Anesthesiologists (ASA)
score.2,4 Another study matched patients by using the National
Nosocomial Infections Surveillance (NNIS) system risk index
score, which incorporates duration of surgery, wound class,
and ASA score.1 However, recent data in pediatrics suggest
that the NNIS risk index did not adequately stratify pediatric
patients who underwent median sternotomy according to
their risk of developing an SSI.6
St. Louis Children’s Hospital has performed prospective
surveillance for cardiothoracic SSI since 2000. An increasing
incidence of SSI was detected between 2001 and 2003. The
rate increased from 1.4% (8 of 563 patients) in 2001 to 3.1%
(17 of 541) in 2002, and then increased to 4.8% (23 of 476)
in 2003 ( ). Most infections that occurred duringPp .002
2002-2003 (26 of 40 infections [65%]) were deep SSIs. A
retrospective case-control study was performed to investigate
this increase.
methods
Case patients who underwent surgery during the period
from January 1, 2002, through December 31, 2003, were
evaluated. Patients underwent procedures involving median
sternotomy or posterolateral incision and were followed up
for infection for up to 1 year if the procedure involved place-
ment of an implant. Three control patients were selected per
case patient. Control patients were matched on the basis of
month and year of procedure. Institutional review board ap-
proval was obtained.
A standardized data collection tool was used. Data on de-
mographic, microbiologic, preoperative, intraoperative, and
postoperative variables were collected. The outcomes inves-
tigated included pediatric intensive care unit (PICU) length
of stay, hospital length of stay, and mortality.
Statistical analysis was performed using SPSS statistical
software, version 14.0 (SPSS). Univariate analysis using the
Student t test, x2 test, and Fisher exact test, as appropriate,
was performed to determine the risk factors for SSI. P values
were 2-tailed. P of .05 or less was considered statistically
significant. Adjusted odds ratios (ORs) and 95% confidence
intervals (CIs) were computed. The variables determined to
be significant by univariate analysis and variables that had a
priori clinical significance were entered into a multivariate
model. Significant variables that covaried were grouped, and
1 variable from each group was chosen for entry into the
model. The final model was chosen on the basis of biological
plausibility and lowest 2 log likelihood function.
SSI was defined in accordance with Centers for Disease
Control and Prevention and NNIS criteria.7 Deep SSI involved
soft tissues below the subcutaneous layer, including bone and
mediastinum. Clinical criteria included purulent drainage
from incision, incision dehisced or opened in a patient with
fever or localized tenderness, or deep incisional SSI diagnosed
by the surgeon or attending physician. SSIs were tracked for
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(n p 120) OR (95% CI) P
Patient characteristic
Weight, mean  SD, kg 7.9  7.1 19.0 22 .003
Age, mean SD, months 19.8 34 51.0 65 .004
Cyanotic heart disease 19 (48) 40 (33) 2.2 (1.1-4.6) .03
Preoperative risk factors
Infection at time of surgery 9 (22) 7 (7) 4.1 (1.5-11.4) .008
Preoperative NICU stay 11 (28) 14 (11) 2.9 (1.2-7.0) .02
Same-day surgery, preoperatively 7 (17) 55 (46) 0.25 (0.10-0.61) .002
Intraoperative risk factors
Receipt of prostaglandin 10 (25) 11 (9) 3.3 (1.3-8.5) .01
Surgery performed on a Monday 14 (35) 17 (14) 3.3 (1.4-7.5) .005
Blalock-Taussig shunt procedure 8 (20) 4 (3) 7.3 (2.1-25.6) .002
Tricuspid procedure 5 (12) 2 (2) 8.4 (1.6-45.3) .01
Multiple procedures 25 (63) 39 (32) 3.5 (1.6-7.3) .001
ASA score 13 22 (55) 35 (29) 3.0 (1.4-6.2) .004
Implant 30 (75) 68 (57) 2.3 (1.0-5.1) .04
Subclavian line placed in operating room 20 (50) 38 (32) 2.2 (1.0-4.5) .04
Intraoperative PRBC transfusion 30 (75) 67 (56) 2.4 (1.1-5.3) .03
Procedure duration, mean SD, min 209.3  102.2 209.9  98.2 .97
Cardiopulmonary bypass pump used 30 (75) 99 (83) 0.64 (0.27-1.5) .3
Intraoperative glucose level,
mean SD (range), mg/dL 238.1  102.5 (73-463) 267.3  91.7 (99-476) .13
Lowest intraoperative temperature,
mean SD (range), C 28.3 6.3 (14.8-36.5) 30.0 5.2 (15.8-37.0) .11
Antibiotic prophylaxis administered
within 60 min of incisiona 20 (50) 75 (62) 0.6 (0.28-1.3) .19
Postoperative risk factor
Sternum left open postoperatively 10 (25) 13 (11) 2.7 (1.1-6.8) .03
note. Data are no. (%) of patients, unless otherwise indicated. ASA, American Society of Anesthesiologists; CI, confidence interval;
MRSA, methicillin-resistant Staphylococcus aureus; NICU, neonatal intensive care unit; OR, odds ratio; PRBC, packed red blood cells.
a Cefazolin or vancomycin if patients had a b–lactam allergy or an MRSA-positive culture result.
30 days or for 1 year from the operative procedure when the
procedure involved placement of an implant.
Superficial SSI involved the skin and subcutaneous tissue.
Clinical criteria included purulent drainage from incision;
organism(s) isolated from culture of incision samples; symp-
toms of tenderness, localized swelling or erythema; and su-
perficial incision deliberately opened by the surgeon or di-
agnosis of superficial SSI made by the surgeon or attending
physician. The ASA score was used to control for underlying
severity of illness.8
The primary outcome of interest was SSI. Secondary out-
comes were death and length of stay in the hospital and the
PICU. The secondary outcome risk attributed to SSI was
determined by multivariate logistic regression, for which pres-
ence of SSI along with ASA score were entered for each
outcome.
results
A total of 1,017 surgical procedures were included in the 24-
month study period. Forty case patients and 120 control pa-
tients were analyzed. Monthly SSI rates ranged from 1% to
10.3%. The median time to onset of infection was 9.0 days
(range, 2.0-82.0 days). Twenty-six (65%) of 40 SSIs were deep,
and 14 (35%) were superficial.
The organisms isolated from patients with SSI, according
to type of SSI, are listed in Table 1. Coagulase-negative Staph-
ylococcus (CoNS) was the organism most commonly recov-
ered. Eight patients had secondary bloodstream infections due
to CoNS, Staphylococcus aureus, Klebsiella pneumoniae, or
methicillin-resistant Staphylococcus aureus.
Significant risk factors for SSI by univariate analysis are
listed in Table 2. Weight (less than 4.5 kg), age (less than 2.5
months), and increased ASA score (greater than 3) were sig-
nificant and strongly correlated. An ASA score greater than
3 was used in the multivariate logistic regression model. In-
dependent risk factors for cardiothoracic SSI included having
had more than 1 cardiothoracic procedure performed in the
operating room (OR, 3.6 [95% CI, 1.5-9.0]; ); an-Pp .005
other infection present or being treated at the time of surgery,
as documented in the patient’s medical record (OR, 5.5 [95%
CI, 1.4-22.0]; ); and having surgery performed onPp .015
a Monday (OR, 5.6 [95% CI, 2.0-15.4]; ). Docu-Pp .001
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mented preoperative infections included 3 cases of bacteremia
(2 due to CoNS and 1 due to CoNS, K. pneumoniae, and
Enterobacter species), 1 case of endocarditis, 2 upper respi-
ratory tract infections, and 3 urinary tract infections. Two
cases of SSIs due to CoNS occurred in bacteremic patients.
Procedures performed on all days of the week were ana-
lyzed, but only procedures performed on a Monday were
found to be significantly associated with cardiothoracic SSI.
No individual healthcare worker or worker job category was
associated with surgery performed on a Monday or with car-
diothoracic SSI. No differences in the nursing, perfusion, or
environmental services involved in preparation for surgery
on Monday were identified, compared with those used on
other days of the week.
When patients with SSI were compared with patients with-
out SSI, PICU length of stay (18.9 vs 4.5 days; ) andP ! .001
hospital length of stay (mean, 35.6 vs 12.4 days; )Pp .003
were significantly increased. A total of 5 patients with SSI
died, 4 of whom had a deep SSI. After controlling for ASA
score, patients with deep SSI had an increased risk of death
(OR, 4.9 [95% CI, 1.1-22.8]; ).Pp .04
discussion
A significant increase in the rate of cardiothoracic SSI at St.
Louis Children’s Hospital was identified on the basis of his-
torical surveillance data. If a patient had more than 1 car-
diothoracic surgical procedure performed concurrently or
had an infection present preoperatively, these factors could
plausibly increase the risk of SSI because these variables reflect
the patient’s underlying severity of illness and/or immune
function and could increase surgical complexity. Procedure
time did not vary between case and control patients, and
therefore surgical duration could not explain the increased
SSI risk associated with multiple procedures. Concurrent in-
fections also increase the microbial burden and have been
shown to increase the SSI risk in other studies.5 The increased
risk of infection associated with surgery performed on a Mon-
day is difficult to explain. No obvious difference in the com-
plexity of cases was noted on any particular day of the week.
Unfortunately, this finding remains difficult to explain.
Several risk factors associated with SSI in adults were not
significant in this study.9,10 For example, administration of
antibiotic prophylaxis within 60 minutes of incision time was
not significant. However, during the study period, the rate
of compliance with timing guidelines for antibiotic prophy-
laxis was low for case and control patients. Similarly, intra-
operative hyperglycemia was also not associated with in-
creased risk of SSI, but both groups had similarly elevated
glucose levels, making it difficult to discern any significance.
This study represents a single center’s experience with a
limited number of cases. A small number of patients under-
went each cardiac procedure, which meant that they could
not be matched by procedure type. Similarly, sample size
prevented us from matching patients by age or weight. How-
ever, age and weight were strongly correlated with ASA score.
When we controlled for age, weight, or ASA score in the
multivariate models, results were similar. Finally, the ASA
score is not a pediatric patient–specific score. Lack of a stan-
dardized pediatric preoperative risk score limits risk strati-
fication in children.6
On the basis of this study, it appears prudent to avoid
performing surgery for patients with underlying infections in
the immediate preoperative period. Further studies of pedi-
atric SSI that involve multiple centers’ experience and in-
creased numbers of patients would be ideal. Establishing
standardized interhospital comparisons would better enable
benchmarking among institutions.
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